REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1

Cell Cycle

Volumn 12, Issue 2, 2013, Pages 365-378

  Chun, Abel Chiu Shun ^a   Kok, Kin Hang ^a   Jin, Dong Yan ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anaphase promoting complex; DNA damage tolerance; REV1; REV7; Translesion DNA synthesis

Indexed keywords

ANAPHASE PROMOTING COMPLEX; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CELL CYCLE PROTEIN 20; DNA POLYMERASE; DNA POLYMERASE REV1; DNA POLYMERASE REV7; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UVOMORULIN;

AMINO TERMINAL SEQUENCE; ANAPHASE; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; DNA REPLICATION; DNA SYNTHESIS; EMBRYO; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA INTERFERENCE; UBIQUITINATION;

EID: 84873619237     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23214     Document Type: Article

References (75)

1. McCulloch SD, Kunkel TA. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res 2008; 18:148-61; PMID:18166979; http://dx.doi.org/10.1038/cr.2008.4.
2. Prakash S, Johnson RE, Prakash L. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem 2005; 74:317- 53; PMID:15952890; http://dx.doi.org/10.1146/annurev.biochem.74.082803. 133250.
3. Lange SS, Takata K, Wood RD. DNA polymerases and cancer. Nat Rev Cancer 2011; 11:96-110; PMID:21258395; http://dx.doi.org/10.1038/nrc2998.
4. Waters LS, Minesinger BK, Wiltrout ME, D'Souza S, Woodruff RV, Walker GC. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol Mol Biol Rev 2009; 73:134- 54; PMID:19258535; http://dx.doi.org/10.1128/MMBR.00034-08.
5. Wittschieben JP, Patil V, Glushets V, Robinson LJ, Kusewitt DF, Wood RD. Loss of DNA polymerase ζ enhances spontaneous tumorigenesis. Cancer Res 2010; 70:2770-8; PMID:20215524; http://dx.doi.org/10.1158/0008-5472.CAN-09-4267.
6. Doles J, Oliver TG, Cameron ER, Hsu G, Jacks T, Walker GC, et al. Suppression of Rev3, the catalytic subunit of Polζ, sensitizes drug-resistant lung tumors to chemotherapy. Proc Natl Acad Sci USA 2010; 107:20786-91; PMID:21068376; http://dx.doi.org/10.1073/pnas.1011409107.
7. Kim H, Yang K, Dejsuphong D, D'Andrea AD. Regulation of Rev1 by the Fanconi anemia core complex. Nat Struct Mol Biol 2012; 19:164-70; PMID:22266823; http://dx.doi.org/10.1038/nsmb.2222.
8. Kim N, Mudrak SV, Jinks-Robertson S. The dCMP transferase activity of yeast Rev1 is biologically relevant during the bypass of endogenously generated AP sites. DNA Repair (Amst) 2011; 10:1262-71; PMID:22024240; http://dx.doi.org/10.1016/j.dnarep.2011.09.017.
9. Wiltrout ME, Walker GC. The DNA polymerase activity of Saccharomyces cerevisiae Rev1 is biologically significant. Genetics 2011; 187:21-35; PMID:20980236; http://dx.doi.org/10.1534/genetics.110.124172.
10. Guo C, Sonoda E, Tang TS, Parker JL, Bielen AB, Takeda S, et al. REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro and in vivo. Mol Cell 2006; 23:265-71; PMID:16857592; http://dx.doi.org/10.1016/j. molcel.2006.05.038.
11. Wood A, Garg P, Burgers PM. A ubiquitin-binding motif in the translesion DNA polymerase Rev1 mediates its essential functional interaction with ubiquitinated proliferating cell nuclear antigen in response to DNA damage. J Biol Chem 2007; 282:20256- 63; PMID:17517887; http://dx.doi.org/10.1074/jbc. M702366200.
12. Guo C, Fischhaber PL, Luk-Paszyc MJ, Masuda Y, Zhou J, Kamiya K, et al. Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. EMBO J 2003; 22:6621-30; PMID:14657033; http://dx.doi.org/10.1093/emboj/cdg626.
13. Ohashi E, Hanafusa T, Kamei K, Song I, Tomida J, Hashimoto H, et al. Identification of a novel REV1-interacting motif necessary for DNA polymerase κ function. Genes Cells 2009; 14:101-11; PMID:19170759; http://dx.doi.org/10.1111/j.1365-2443.2008.01255.x.
14. Ross AL, Simpson LJ, Sale JE. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1. Nucleic Acids Res 2005; 33:1280-9; PMID:15741181; http://dx.doi.org/10.1093/nar/gki279.
15. Acharya N, Johnson RE, Prakash S, Prakash L. Complex formation with Rev1 enhances the proficiency of Saccharomyces cerevisiae DNA polymerase ζ for mismatch extension and for extension opposite from DNA lesions. Mol Cell Biol 2006; 26:9555- 63; PMID:17030609; http://dx.doi.org/10.1128/MCB.01671-06.
16. Acharya N, Haracska L, Johnson RE, Unk I, Prakash S, Prakash L. Complex formation of yeast Rev1 and Rev7 proteins: a novel role for the polymeraseassociated domain. Mol Cell Biol 2005; 25:9734- 40; PMID:16227619; http://dx.doi.org/10.1128/MCB.25.21.9734-9740.2005.
17. D'Souza S, Walker GC. Novel role for the C terminus of Saccharomyces cerevisiae Rev1 in mediating proteinprotein interactions. Mol Cell Biol 2006; 26:8173- 82; PMID:16923957; http://dx.doi.org/10.1128/MCB.00202-06.
18. Kosarek JN, Woodruff RV, Rivera-Begeman A, Guo C, D'Souza S, Koonin EV, et al. Comparative analysis of in vivo interactions between Rev1 protein and other Y-family DNA polymerases in animals and yeasts. DNA Repair (Amst) 2008; 7:439-51; PMID:18242152; http://dx.doi.org/10.1016/j.dnarep.2007.11.016.
19. Sharma S, Hicks JK, Chute CL, Brennan JR, Ahn JY, Glover TW, et al. REV1 and polymerase ζ facilitate homologous recombination repair. Nucleic Acids Res 2012; 40:682-91; PMID:21926160; http://dx.doi.org/10.1093/nar/gkr769.
20. Hara K, Hashimoto H, Murakumo Y, Kobayashi S, Kogame T, Unzai S, et al. Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase ζ and REV1. J Biol Chem 2010; 285:12299-307; PMID:20164194; http://dx.doi.org/10.1074/ jbc.M109.092403.
21. Gan GN, Wittschieben JP, Wittschieben BO, Wood RD. DNA polymerase zeta (pol zeta) in higher eukaryotes. Cell Res 2008; 18:174-83; PMID:18157155; http://dx.doi.org/10.1038/cr.2007.117.
22. Nelson JR, Lawrence CW, Hinkle DC. Thyminethymine dimer bypass by yeast DNA polymerase ζ. Science 1996; 272:1646-9; PMID:8658138; http://dx.doi.org/10.1126/science.272.5268.1646.
23. Takeuchi R, Oshige M, Uchida M, Ishikawa G, Takata K, Shimanouchi K, et al. Purification of Drosophila DNA polymerase ζ by REV1 proteinaffinity chromatography. Biochem J 2004; 382:535- 43; PMID:15175013; http://dx.doi.org/ 10.1042/BJ20031833.
24. Cheung HW, Chun AC, Wang Q, Deng W, Hu L, Guan XY, et al. Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents. Cancer Res 2006; 66:4357-67; PMID:16618761; http://dx.doi.org/10.1158/0008-5472.CAN-05-3602.
25. Okada T, Sonoda E, Yoshimura M, Kawano Y, Saya H, Kohzaki M, et al. Multiple roles of vertebrate REV genes in DNA repair and recombination. Mol Cell Biol 2005; 25:6103-11; PMID:15988022; http://dx.doi.org/10.1128/MCB.25.14.6103- 6111.2005.
26. McNally K, Neal JA, McManus TP, McCormick JJ, Maher VM. hRev7, putative subunit of hPolzeta, plays a critical role in survival, induction of mutations, and progression through S-phase, of UV((254nm))- irradiated human fibroblasts. DNA Repair (Amst) 2008; 7:597-604; PMID:18295554; http://dx.doi.org/10.1016/j. dnarep.2007.12.013.
27. Cahill DP, da Costa LT, Carson-Walter EB, Kinzler KW, Vogelstein B, Lengauer C. Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics 1999; 58:181-7; PMID:10366450; http://dx.doi.org/10.1006/geno. 1999.5831.
28. Murakumo Y, Roth T, Ishii H, Rasio D, Numata S, Croce CM, et al. A human REV7 homolog that interacts with the polymerase ζ catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. J Biol Chem 2000; 275:4391-7; PMID:10660610; http://dx.doi.org/10.1074/jbc.275.6.439129.
29. Chen J, Fang G. MAD2B is an inhibitor of the anaphase- promoting complex. Genes Dev 2001; 15:1765- 70; PMID:11459826; http://dx.doi.org/10.1101/gad. 898701.
30. Pfleger CM, Salic A, Lee E, Kirschner MW. Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating Cdh1. Genes Dev 2001; 15:1759-64; PMID:11459825; http://dx.doi.org/10.1101/gad.897901.
31. Eytan E, Moshe Y, Braunstein I, Hershko A. Roles of the anaphase-promoting complex/cyclosome and of its activator Cdc20 in functional substrate binding. Proc Natl Acad Sci USA 2006; 103:2081-6; PMID:16455800; http://dx.doi.org/10.1073/pnas.0510695103.
32. Yu H. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol Cell 2007; 27:3-16; PMID:17612486; http://dx.doi.org/10.1016/j.molcel.2007.06. 009.
33. Qiao X, Zhang L, Gamper AM, Fujita T, Wan Y. APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity. Cell Cycle 2010; 9:3904- 12; PMID:20935501; http://dx.doi.org/10.4161/cc.9.19.13585.
34. Glotzer M, Murray AW, Kirschner MW. Cyclin is degraded by the ubiquitin pathway. Nature 1991; 349:132-8; PMID:1846030; http://dx.doi.org/10.1038/ 349132a0.
35. Pfleger CM, Kirschner MW. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev 2000; 14:655-65; PMID:10733526.
36. Wang Y, Zhan Q. Cell cycle-dependent expression of centrosomal ninein-like protein in human cells is regulated by the anaphase-promoting complex. J Biol Chem 2007; 282:17712-9; PMID:17403670; http://dx.doi.org/10. 1074/jbc.M701350200.
37. Park HJ, Costa RH, Lau LF, Tyner AL, Raychaudhuri P. Anaphase-promoting complex/cyclosome-CDH1- mediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase. Mol Cell Biol 2008; 28:5162-71; PMID:18573889; http://dx.doi.org/10.1128/MCB.00387-08.
38. Littlepage LE, Ruderman JV. Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. Genes Dev 2002; 16:2274-85; PMID:12208850; http://dx.doi.org/10.1101/gad.1007302.
39. Reis A, Levasseur M, Chang HY, Elliott DJ, Jones KT. The CRY box: a second APCcdh1-dependent degron in mammalian cdc20. EMBO Rep 2006; 7:1040- 5; PMID:16878123; http://dx.doi.org/10.1038/sj.embor.7400772.
40. Iwai H, Kim M, Yoshikawa Y, Ashida H, Ogawa M, Fujita Y, et al. A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell 2007; 130:611-23; PMID:17719540; http://dx.doi.org/10.1016/j.cell. 2007.06.043.
41. Ying B, Wold WS. Adenovirus ADP protein (E3-11.6K), which is required for efficient cell lysis and virus release, interacts with human MAD2B. Virology 2003; 313:224-34; PMID:12951035; http://dx.doi.org/10.1016/S0042-6822(03)00287- 3.
42. Garg P, Burgers PM. Ubiquitinated proliferating cell nuclear antigen activates translesion DNA polymerases η and REV1. Proc Natl Acad Sci USA 2005; 102:18361-6; PMID:16344468; http://dx.doi.org/10.1073/pnas.0505949102.
43. Skoneczna A, McIntyre J, Skoneczny M, Policinska Z, Sledziewska-Gojska E. Polymerase η is a short-lived, proteasomally degraded protein that is temporarily stabilized following UV irradiation in Saccharomyces cerevisiae. J Mol Biol 2007; 366:1074-86; PMID:17198712; http://dx.doi.org/10.1016/j.jmb.2006. 11.093.
44. Jung YS, Liu G, Chen X. Pirh2 E3 ubiquitin ligase targets DNA polymerase η for 20S proteasomal degradation. Mol Cell Biol 2010; 30:1041-8; PMID:20008555; http://dx.doi.org/10.1128/MCB.01198-09.
45. Jung YS, Qian Y, Chen X. DNA polymerase η is targeted by Mdm2 for polyubiquitination and proteasomal degradation in response to ultraviolet irradiation. DNA Repair (Amst) 2012; 11:177-84; PMID:22056306; http://dx.doi.org/10.1016/j.dnarep.2011.10.017.
46. Wimmer U, Ferrari E, Hunziker P, Hübscher U. Control of DNA polymerase λ stability by phosphorylation and ubiquitination during the cell cycle. EMBO Rep 2008; 9:1027-33; PMID:18688254; http://dx.doi.org/10.1038/ embor.2008.148.
47. Waters LS, Walker GC. The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G(2)/M phase rather than S phase. Proc Natl Acad Sci USA 2006; 103:8971-6; PMID:16751278; http://dx.doi.org/10.1073/pnas. 0510167103.
48. Sabbioneda S, Bortolomai I, Giannattasio M, Plevani P, Muzi-Falconi M. Yeast Rev1 is cell cycle regulated, phosphorylated in response to DNA damage and its binding to chromosomes is dependent upon MEC1. DNA Repair (Amst) 2007; 6:121-7; PMID:17035102; http://dx.doi.org/10.1016/j.dnarep.2006.09.002.
49. Pozo FM, Oda T, Sekimoto T, Murakumo Y, Masutani C, Hanaoka F, et al. Molecular chaperone Hsp90 regulates REV1-mediated mutagenesis. Mol Cell Biol 2011; 31:3396-409; PMID:21690293; http://dx.doi.org/10.1128/MCB.05117-11.
50. Wiltrout ME, Walker GC. Proteasomal regulation of the mutagenic translesion DNA polymerase, Saccharomyces cerevisiae Rev1. DNA Repair (Amst) 2011; 10:169-75; PMID:21227758; http://dx.doi.org/10.1016/j.dnarep.2010.10.008.
51. Guo C, Tang TS, Bienko M, Parker JL, Bielen AB, Sonoda E, et al. Ubiquitin-binding motifs in REV1 protein are required for its role in the tolerance of DNA damage. Mol Cell Biol 2006; 26:8892- 900; PMID:16982685; http://dx.doi.org/10.1128/MCB.01118-06.
52. D'Souza S, Waters LS, Walker GC. Novel conserved motifs in Rev1 C-terminus are required for mutagenic DNA damage tolerance. DNA Repair (Amst) 2008; 7:1455-70; PMID:18603483; http://dx.doi.org/10.1016/j.dnarep.2008.05.009.
53. Chun AC, Jin DY. Ubiquitin-dependent regulation of translesion polymerases. Biochem Soc Trans 2010; 38:110-5; PMID:20074045; http://dx.doi.org/10.1042/BST0380110.
54. Wan Y, Liu X, Kirschner MW. The anaphase-promoting complex mediates TGF-β signaling by targeting SnoN for destruction. Mol Cell 2001; 8:1027-39; PMID:11741538; http://dx.doi.org/10.1016/S1097-2765(01)00382-3.
55. Gutierrez GJ, Tsuji T, Chen M, Jiang W, Ronai ZA. Interplay between Cdh1 and JNK activity during the cell cycle. Nat Cell Biol 2010; 12:686-95; PMID:20581839; http://dx.doi.org/10.1038/ncb2071.
56. Horn SR, Thomenius MJ, Johnson ES, Freel CD, Wu JQ, Coloff JL, et al. Regulation of mitochondrial morphology by APC/CCdh1-mediated control of Drp1 stability. Mol Biol Cell 2011; 22:1207-16; PMID:21325626; http://dx.doi.org/10. 1091/mbc.E10-07-0567.
57. Zhang L, Park CH, Wu J, Kim H, Liu W, Fujita T, et al. Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress. EMBO J 2010; 29:1726-37; PMID:20424596; http://dx.doi.org/10.1038/emboj. 2010.55.
58. Cui Y, Cheng X, Zhang C, Zhang Y, Li S, Wang C, et al. Degradation of the human mitotic checkpoint kinase Mps1 is cell cycle-regulated by APCcCdc20 and APC-cCdh1 ubiquitin ligases. J Biol Chem 2010; 285:32988-98; PMID:20729194; http://dx.doi.org/10.1074/jbc.M110.140905.
59. Izawa D, Pines J. How APC/C-Cdc20 changes its substrate specificity in mitosis. Nat Cell Biol 2011; 13:223-33; PMID:21336306; http://dx.doi.org/10. 1038/ncb2165.
60. Cotto-Rios XM, Jones MJ, Busino L, Pagano M, Huang TT. APC/CCdh1-dependent proteolysis of USP1 regulates the response to UV-mediated DNA damage. J Cell Biol 2011; 194:177-86; PMID:21768287; http://dx.doi.org/10. 1083/jcb.201101062.
61. Castro A, Vigneron S, Bernis C, Labbé JC, Lorca T. Xkid is degraded in a D-box, KEN-box, and A-boxindependent pathway. Mol Cell Biol 2003; 23:4126- 38; PMID:12773557; http://dx.doi.org/10.1128/MCB.23.12.4126-4138.2003.
62. Araki M, Yu H, Asano M. A novel motif governs APC-dependent degradation of Drosophila ORC1 in vivo. Genes Dev 2005; 19:2458-65; PMID:16195415; http://dx.doi.org/10.1101/gad.1361905.
63. Jin L, Williamson A, Banerjee S, Philipp I, Rape M. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 2008; 133:653- 65; PMID:18485873; http://dx.doi.org/10.1016/j.cell.2008.04.012.
64. Kraft C, Vodermaier HC, Maurer-Stroh S, Eisenhaber F, Peters JM. The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol Cell 2005; 18:543-53; PMID:15916961; http://dx.doi.org/10.1016/ j.molcel.2005.04.023.
65. Chow C, Wong N, Pagano M, Lun SW, Nakayama KI, Nakayama K, et al. Regulation of APC/CCdc20 activity by RASSF1A-APC/CCdc20 circuitry. Oncogene 2012; 31:1975-87; PMID:21874044; http://dx.doi.org/10.1038/onc.2011.372.
66. Masuda Y, Ohmae M, Masuda K, Kamiya K. Structure and enzymatic properties of a stable complex of the human REV1 and REV7 proteins. J Biol Chem 2003; 278:12356-60; PMID:12529368; http://dx.doi.org/10.1074/jbc.M211765200.
67. Murakumo Y, Ogura Y, Ishii H, Numata S, Ichihara M, Croce CM, et al. Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7. J Biol Chem 2001; 276:35644-51; PMID:11485998; http://dx.doi.org/10. 1074/jbc.M102051200.
68. Hashimoto K, Cho Y, Yang IY, Akagi J, Ohashi E, Tateishi S, et al. The vital role of polymerase ζ and REV1 in mutagenic, but not correct, DNA synthesis across benzo[a]pyrene-dG and recruitment of polymerase ζ by REV1 to replication-stalled site. J Biol Chem 2012; 287:9613-22; PMID:22303021; http://dx.doi.org/10.1074/jbc.M111.331728.
69. Lawrence CW, Das G, Christensen RB. REV7, a new gene concerned with UV mutagenesis in yeast. Mol Gen Genet 1985; 200:80-5; PMID:3897794; http://dx.doi.org/10.1007/BF00383316.
70. Rajpal DK, Wu X, Wang Z. Alteration of ultravioletinduced mutagenesis in yeast through molecular modulation of the REV3 and REV7 gene expression. Mutat Res 2000; 461:133-43; PMID:11018586; http://dx.doi.org/10.1016/S0921-8777(00) 00047-1.
71. Treier M, Staszewski LM, Bohmann D. Ubiquitindependent c-Jun degradation in vivo is mediated by the δ domain. Cell 1994; 78:787-98; PMID:8087846; http://dx.doi.org/10.1016/S0092-8674(94)90502-9.
72. Zhou Y, Ching YP, Chun AC, Jin DY. Nuclear localization of the cell cycle regulator CDH1 and its regulation by phosphorylation. J Biol Chem 2003; 278:12530- 6; PMID:12560341; http://dx.doi.org/10.1074/jbc.M212853200.
73. Turner DL, Weintraub H. Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev 1994; 8:1434- 47; PMID:7926743; http://dx.doi.org/10.1101/gad.8.12.1434.
74. Chan CP, Mak TY, Chin KT, Ng IOL, Jin DY. N-linked glycosylation is required for optimal proteolytic activation of membrane-bound transcription factor CREB-H. J Cell Sci 2010; 123:1438- 48; PMID:20356926; http://dx.doi.org/10.1242/jcs.067819.
75. Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 1986; 234:179-86; PMID:3018930; http://dx.doi.org/10.1126/science.3018930.